These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12233921)

  • 1. Safety of electrical cardioversion in patients with atrial fibrillation.
    Gentile F; Elhendy A; Khandheria BK; Seward JB; Lohse CM; Shen WK; Bailey KR; Montgomery SC; Burger KN; Tajik AJ
    Mayo Clin Proc; 2002 Sep; 77(9):897-904. PubMed ID: 12233921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of electrical cardioversion in patients with previous embolic events.
    Elhendy A; Gentile F; Khandheria BK; Bailey KR; Burger KN; Seward JB
    Mayo Clin Proc; 2001 Apr; 76(4):364-8. PubMed ID: 11322351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study.
    Airaksinen KE; Grönberg T; Nuotio I; Nikkinen M; Ylitalo A; Biancari F; Hartikainen JE
    J Am Coll Cardiol; 2013 Sep; 62(13):1187-92. PubMed ID: 23850908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
    Kinch JW; Davidoff R
    Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].
    Klein HH
    Dtsch Med Wochenschr; 2013 Jun; 138(24):1309-11. PubMed ID: 23737116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study).
    Grönberg T; Hartikainen JE; Nuotio I; Biancari F; Ylitalo A; Airaksinen KE
    Am J Cardiol; 2016 Apr; 117(8):1294-8. PubMed ID: 26892448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.
    Seidl K; Rameken M; Drögemüller A; Vater M; Brandt A; Schwacke H; Bergmeier C; Zahn R; Senges J
    J Am Coll Cardiol; 2002 May; 39(9):1436-42. PubMed ID: 11985904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversion.
    Själander S; Svensson PJ; Friberg L
    Int J Cardiol; 2016 Jul; 215():360-3. PubMed ID: 27128562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ineffective anticoagulation prior to elective electric cardioversion for atrial fibrillation. Results of transesophageal echocardiography].
    Stopp M; Kristen C; Sybrecht GW; Jung J
    Dtsch Med Wochenschr; 2003 Jun; 128(23):1277-81. PubMed ID: 12789636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation for cardioversion of atrial fibrillation.
    El Gendi H; Ismail T; Charalampos K; Mayet J
    Minerva Cardioangiol; 2002 Feb; 50(1):43-52. PubMed ID: 11830718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic complications after electrical cardioversion in patients with atrial flutter.
    Elhendy A; Gentile F; Khandheria BK; Gersh BJ; Bailey KR; Montgomery SC; Seward JB; Tajik AJ
    Am J Med; 2001 Oct; 111(6):433-8. PubMed ID: 11690567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
    Flaker G; Lopes RD; Al-Khatib SM; Hermosillo AG; Hohnloser SH; Tinga B; Zhu J; Mohan P; Garcia D; Bartunek J; Vinereanu D; Husted S; Harjola VP; Rosenqvist M; Alexander JH; Granger CB;
    J Am Coll Cardiol; 2014 Mar; 63(11):1082-7. PubMed ID: 24211508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.
    Manning WJ; Silverman DI; Keighley CS; Oettgen P; Douglas PS
    J Am Coll Cardiol; 1995 May; 25(6):1354-61. PubMed ID: 7722133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioversion for atrial fibrillation - how to prevent thromboembolic complications?
    Jaakkola S; Kiviniemi TO; Airaksinen KEJ
    Ann Med; 2018 Nov; 50(7):549-555. PubMed ID: 30207497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioversion related thromboembolism: value of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
    Seidl K; Senges J
    Card Electrophysiol Rev; 2003 Dec; 7(4):392-6. PubMed ID: 15071262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of transesophageal echocardiography in the therapeutic management of non-valvular atrial fibrillation].
    Baubion N
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1291-5. PubMed ID: 8952827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
    Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of transoesophageal echocardiography before cardioversion in patients with atrial fibrillation and different anticoagulant regimens.
    Maltagliati A; Galli CA; Tamborini G; Calligaris A; Doria E; Salehi R; Pepi M
    Heart; 2006 Jul; 92(7):933-8. PubMed ID: 16284221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.
    Hellman T; Kiviniemi T; Nuotio I; Vasankari T; Hartikainen J; Lip GYH; Airaksinen KEJ
    Thromb Res; 2017 Aug; 156():163-167. PubMed ID: 28662483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.